This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, Institut Pasteur, Institut Pasteur Du Cambodge. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2024
Title: The Innovations of Valentine Duru
Introduction
Valentine Duru is a notable inventor based in Le Pré Saint Gervais, France. He has made significant contributions to the field of malaria research, particularly in the detection of piperaquine-resistant Plasmodium falciparum malaria. His work has implications for improving treatment methods and patient outcomes.
Latest Patents
Valentine Duru holds a patent for "Methods and reagents for detecting piperaquine-resistant Plasmodium falciparum malaria." This patent outlines a method for genotyping that includes providing a sample containing the pathogen and detecting the presence of an increased copy number of the genomic plasmepsin2-3 cluster. Additionally, it describes a method for detecting infection in a patient by analyzing a blood sample for the same genomic markers. The patent also includes kits for genotyping and methods for treating the infection.
Career Highlights
Throughout his career, Valentine Duru has worked with prestigious institutions such as Institut Pasteur and Institut Pasteur du Cambodge. His research has focused on developing innovative methods for diagnosing and treating malaria, contributing to the global fight against this disease.
Collaborations
Valentine Duru has collaborated with esteemed colleagues in his field, including Didier Menard and Benjamin Saint Pierre. These partnerships have enhanced the impact of his research and have led to advancements in malaria detection and treatment.
Conclusion
Valentine Duru's contributions to malaria research through his innovative patent and collaborations highlight his commitment to improving healthcare outcomes. His work continues to influence the field and offers hope for better management of malaria infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile